Mural Oncology, Inc

“Mural Oncology’s goal is to efficiently bring safe and effective medicines to all appropriate patients by conducting rigorous clinical trials and obtaining marketing approval by regulatory authorities, including the U.S. Food and Drug Administration (FDA). Prior to such approval, participation in one of our clinical trials is the optimal way for patients to gain access to our investigational medicines. However, we understand that some patients may not be able to participate in a clinical trial and may seek access to investigational treatments before they are approved. If early data from preclinical and clinical trials suggest that an investigational treatment can offer benefits for patients facing serious or life-threatening conditions, Mural Oncology may consider requests to provide access outside of a clinical study.”